Dr Colin Wood is a Research Fellow in the Survivorship group within the Department of Health Services Research at the Peter MacCallum Cancer Centre.
Dr Wood earned his PhD investigating analysis of health data through applied machine learning involving assimilating and evaluating large, complex data sets, and recently completed a Master of Public Health at the University of Melbourne. Over 10 years of postdoctoral experience in knowledge translation and evidence-based medicine at PeterMac, with a focus on inclusion of consumers in the complete lifecycle of clinical research.
His current research interest is to build capability in health services, survivorship and patient-centred research through grant submissions, collaboration with internal and external colleagues, contributing in research teams and publishing work in peer-reviewed journals and presenting at conferences. He is also active in exploring opportunities to establish novel research methodologies built around monitoring health data employing machine learning and data linkage.
- Chua CC, Lim HY, Chai KL, Ong J, Sim S, Wood C, Dickinson M, Campbell P, Hempton J, King H, Dowsing C, Bergin K, Muir S, Gibbs S, Grigg A. Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma. Bone Marrow Transplantation. March 2018. (doi.org/10.1038/s41409-018-0152-2)
- An Ke Er J, Routledge J, Hempton J, Wood C, Joyce T, Harrison S, Campbell, P. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Elderly Multiple Myeloma (MM) Patients Aged ≥ 65 Years: A Multi-Centre Australian Experience. November 2018. Blood 132 (Supplement 1):3441-3441 (DOI: 10.1182/blood-2018-99-114049)
- Routledge D. Joyce T., Wood C., Harrison S. PF770 Outcomes for MELPHALAN-VELCADE based autograft in high risk multiple myeloma patients: a single-centre experience. HemaSphere: June 2019 - Volume 3 - Issue S1 - p 339-340 (doi: 10.1097/01.HS9.0000561364.90468.56)
- Routledge D. Joyce T., Wood C., Harrison S. Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥ 65 years: A two-centre Australian experience. Internal Medicine Journal: February 2021 (doi: 10.1111/imj.15182)